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ABSTRACT

Foster care youth are considered a vulnerable
population within society due to the trauma, abuse,
neglect, and placement disruptions that they have

endured. Foster care youth are prescribed psychotropic
medications at a much higher rate than non-foster care

youth due to these factors, which is alarming for
professionals. The purpose of this study was to describe

the trends of foster care youth authorized for

psychotropic medications in Los Angeles County and the
state of California over the last ten years, considering

the trends in age, gender, ethnicity, and placement type.

Significant results show that over age, gender,

ethnicity, and placement type Los Angeles County
authorized psychotropic medication at higher rates than

the state of California over the last ten years.

Limitations of this study were discussed as well as

recommendations for social work practice, policy, and
research.
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CHAPTER ONE

INTRODUCTION

Problem Statement

Foster care is full-time substitute care for
children outside their own home by people other than
their biological or adoptive parents or legal guardians.
With few exceptions, youth who enter foster care have

been physically or sexually abused, or both, and the rate
at which children enter the system is increasing. As of

September 2000, there were approximately 550,000 children

in foster care in the United States

(Perez, Neil,

&

Gesiriech, 2000). By 2001, there were nearly 800,000
children in foster care, with 540,000 children in the
system at any given time (Perez, Neil, & Gesiriech,
2000).

In whole, children in foster care are at higher

risk for developing emotional and behavioral disturbances

and mental illnesses

(Naylor et al.,

2007). It has been

speculated that, as a consequence of this rate,

foster

care youth are more likely to receive psychotropic

medication than in home care youth (Naylor et al., 2007) .
Psychotropic medication can be useful in improving
symptoms associated with a variety of mental health
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disorders; they must be prescribed responsibly, however,

after a complete assessment and thorough knowledge of the

child, parent and situation. Psychotropic medications
work through impacting the amount of specific chemicals

present between neurons in the brain.. Medications
effectively increase or decrease the amount of
neurotransmitters present depending on which is

necessary. With the right dosage and compliance use of
psychotropic medications, most people experience relief

from symptoms

(Bentley, Walsh, Farmer, 2005) . According

to Crimson and Argo change all of these (2007);
psychotropic medications do not create physical

dependence. For many people, psychotropic medications are

an essential component of effective treatment. However,
for the medication to be effective it must be taken
consistently because irregular dosing does not maintain

blood levels that impact brain chemistry (Crimson & Argo,
2007).

The use of psychotropic medication for treatment of

foster care youth has increased over the years (Naylor et
al.,

2007). Additionally,

those foster care youth who are

prescribed psychotropic medications are receiving more

than one prescription (Hunt, 2008). In 2004, 4 in 10
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youth in foster care who received psychotropic medication

were on at least three different classes of drugs, with
at least two being from the same class of medication

(Hunt, 2008) . Numerous studies conclude that the rate of
prescribing psychotropic medication for foster care youth

is approaching that seen among adults

(Crimson & Argo,

2007; Hunt, 2008; Zito et al., 2008b). The rate is
alarming and receives much needed concern; but it is
important to first understand the differences in

utilization between youth's age, ethnicity, placement
type and gender. Understanding these trends will allow
for greater insight with diagnosing patterns and whether

disparities exist in prescribing patterns. In recent
years, the American Academy of Child and Adolescent

Psychiatry has raised concerns about the extent to which
psychotropic medication is used excessively or

inappropriately to treat youth in out of home care

(Hunt,

2008) .
Because children enter foster care under a great

deal of stress, resulting in behavior disorders or

preexisting mental disorders or a combination of both,
thorough assessment of the child, their family, and life
situations is essential in determining their best needs
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(Crimson & Argo, 2 007) . Currently, there are several
pertinent principles to be followed in order to increase
the probability of proper treatment in youth who are

prescribed psychotropic medications. First, while
psychotropic medications can be useful in treatment,

they

should be used in conjunction with a DSM-IV TR diagnosis.

Second,

it is important that the diagnosis is made after

a comprehensive assessment. Third, caregivers need to be
actively involved with the treating clinician. Lastly,

ongoing communication between caregivers,

children, and

clinicians must occur if optimal care outcomes are to be
achieved (Crosson-Tower, 2008).

Present law requires the juvenile courts to approve
psychotropic medications for foster care youth based on

information provided by the child's social worker and
doctor (Childlaw, 2009). Additionally,

in October 2008,

President Bush signed into law Fostering Connections to

Success and Increasing Adoptions Act, PL110-351. The law
requires state child welfare agencies and Medicaid to
provide ongoing oversight and coordination of medical and

mental health services for foster youth (Tufts Clinical,
2010).
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Purpose of the Study

The purpose of this study was to describe the

characteristics of foster care youth authorized for
psychotropic medication in California. Specifically,

the

present study described and compared differences in age,
gender, placement type and ethnicity over a ten-year

period for foster care youth authorized psychotropic
medications in Los Angeles County, and the state of
California as a whole.
Large portions of foster youth are authorized

psychotropic medication. This issue is a concern for

society and child welfare agencies because there is
little consent and oversight for this vulnerable

population's mental health treatment (Naylor et al.,

2007). Foster youth also have a high relocation rate,
which may cause their medical and mental health treatment
to lack continuity because they see multiple physicians

throughout their stay in foster care (Crimson & Argo,
2007).
The issue of psychotropic medication use and foster

youth is continuously being examined and it is pertinent
for individuals working with foster youth to be aware of
the dynamics that accompany the prescription of
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psychotropic medication. In an attempt to gain a broad

overall look at the characteristics of authorized
psychotropic medication, the study utilized a

quantitative descriptive secondary data analysis method.
The researchers extracted individual variables (age,
gender, placement type, and ethnicity)

from the Child

Welfare Research Center (CWRC) online database. CWRC
receives its data from California counties regarding an
array of information pertaining to foster care youth.

However,

the current study focuses specifically on data

pertaining to the authorization of psychotropic

medication for foster care youth. After receiving
approval from the Institutional Review Board (IRB)

the

researchers began extracting data from the periods of

2000-2009. Each variable was extracted individually and
the trends across each characteristic described and
analyzed.

Significance of the Project for Social Work

Knowledge of the trends of authorized psychotropic
medication among foster care youth in California is of

great importance. With the understanding of these trends,

child welfare agencies are able to improve their policies
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pertaining to consent and oversight. Additionally,

child

welfare workers are more informed on how their clients'
age, ethnicity, gender, and placement type may be related

to psychotropic medication prescriptions. Furthermore,
individuals who work directly with foster care youth are

able to be more educated and aware of the issue at hand.
The assessing phase of the generalist intervention

model was informed by the present study. Professionals
and those who have a vested interest in the youth's well
being are more aware of the individual dynamics that
accompany prescribing psychotropic medication. As a

result, a more thorough assessment may be conducted in
which professionals and others can ask themselves whether

current or potential treatment is related to the youth's

specific needs or where they stand on a continuum of

foster youth characteristics.
Examining the use of psychotropic medication in

foster care youth by way of secondary data analysis is an
appropriate method to gain knowledge for child welfare
practice. Social workers are at the forefront of dealing

with foster care youth, and collaborative efforts between
teachers, counselors, and caregivers are made to promote
the best interest of the youth.
7

In completion of this

study we feel we have a better understanding of the

characteristics of foster care youth authorized for
psychotropic medication and the trends of age, gender,

placement type, and ethnicity in Los Angeles County
compared to the greater state of California.
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CHAPTER TWO

LITERATURE REVIEW

Introduction
Chapter two includes a collaboration of valid
research literature that relates to the current study.
This chapter is outlined with sections discussing
relevant research literature on the prevalence of foster

care youth authorized psychotropic medications;
specifically,

trends on age, gender, ethnicity, and

placement types; how insurance type influence
authorization of psychotropic medications, practitioner
influence, and theories that help guide the
conceptualization of this critical social work issue.

Prevalence of Foster Care Youth Being
Prescribed Psychotropic Medications

Youth who enter foster care often have been
physically, emotionally, or sexually abused, neglected,

or witnessed domestic violence. As a result, research
demonstrates that foster care youth are at a higher risk

for developing mental illness, emotional, and behavioral

problems (Burns et al., 2004; Naylor et al., 2004).

Currently, there is an abundance of literature examining
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the use of psychotropic medications among foster care
youth in the United States for this specific reason
(e.g., Naylor et al., 2007; Robst, Armstrong,

& Dollard,

2009) .

Zito et al.

(2008b)

collected a random sample of

Medicaid data for the month of July 2004. The data sample
included 472 medicated youth in foster care ranging from
0

(birth)

through 19 years of age. Zito et al.

(2008b)

examined psychotropic medication treatment data

pertaining to concomitant pattern, frequency, medication

class,

subclass, and drug unit and analyzed it in

relation to age group, gender, race, or ethnicity.
Results found that of the foster care youth prescribed

psychotropic medication, 41.3% received more than three
different classes of these drugs, and 15.9% received more

than four different classes. The results of the study
indicated that 342 medicated foster care youth, out of
472, were receiving concomitant medications. The average

foster care youth was on 2.55 medications
medications for 472 youth)
medications,

(1202

(Zito et al., 2008b). Of these

the most frequent found were antidepressants

(56.8%), attention-deficit/hyperactivity disorder drugs
(55.9%), and antipsychotic agents
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(53.2%). Additionally,

Zito et al.

(2008b)

found that psychiatrists prescribed

93% of the psychotropic medications dispensed to youth in
foster care.

Chen, Gerhard, and Winterstein (2009) used a cohort

sample of 28,763 youth under the age of 21 years who were
newly diagnosed with ADHD within the last six months. The

youth were also eligible for continuous Medicaid. In
order to evaluate the relations between clinical,

socio-demographic, provider characteristics, and the ADHD
medication the researchers used a multivariate logistic

regression. The results concluded that the variables of

being male, school-aged, Caucasian, rural housing, and

foster care are positively linked to initial ADHD
medication treatment (Chen, Gerhard,

& Winterstein,

2009) .

Age

According to the Administration for Children Youth
and Families

(2009),

the mean age of children in foster

care on September 30, 2009 was 9.6 and the median age was
9.7. Also, Robst, Armstrong, and Dollard's 2009 study on

antipsychotic medication use among youth found that

utilization of psychotropic medications was higher among
youth ages 6-12 than that of youth ages 13-18.
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Additionally,

the annual psychotropic medication

prevalence differentiated by age group was 12.4% (0-5

years of age), 55.3% (6-12 years of age), and 66.5%

(13-17 years of age)

(Zito et al., 2008a). Research

findings exemplified that foster care youth prescribed

psychotropic medications peak at 10-14 years of age

(Zito

et al., 2008a). Moreover, 10-14 year olds were 3.5 to 11

times more likely to receive psychotropic medication than

Medicaid insured youth who qualified because of low
family income (Zito et al., 2008a).
Gender

According to the Administration for Children, Youth
and Families 2009), there were 423,773 youth in foster

care with 53%

(222,685) being male and 47%

(200,999)

being female between the dates of October 1, 2008 and
September 20, 2009. Furthermore, Zito et al.

(2008b)

indicated that both boys and girls receive an average of
1.9 psychiatric diagnoses. On the contrary to the

diagnosis, findings showed there was a predominance of

boys being prescribed psychotropic medications

(54.7%)

and receiving more different classes of psychotropic

medications than girls (2.28 vs. 2.06, P < .04)
al., 2008b).
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(Zito et

Ethnicity

According to the Administration of Children, Youth,
and Families

(2009),

the three highest ethnic populations

are Caucasian with 40% (167,235) of foster care youth,
Black with 30% (127,821), and Hispanic

20% (86,581)

(of any race) with

foster care youth. Understanding the racial

disparities throughout the United States' foster care

youth will assist in interpreting the trends for race and
ethnicity with foster care youth authorized psychotropic
medications.

Zito, Safer, dosReis, and Riddle's 2008 study
pertaining to racial disparities found that

African-American youth, compared to Caucasian youth,
between the ages of five and 14, with Medicaid insurance,

were less likely to be prescribed psychotropic
medications

(39% to 52%). In addition, African American

youth had the most contrasting ratio compared to

Caucasian (1:2.5)
Safer, dosReis,

for stimulants (methylphenidate)

& Riddle,

(Zito,

1998). The results indicate

that Caucasian youth receive more psychotropic

medications than African American youth.
Furthermore, race and ethnic backgrounds were found
to have greater psychotropic medication disparities for
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African American youth compared to Hispanic youth
(Caucasian/African American ratio,

1.52:1.00 and

Caucasian/Hispanic ratio, 1.08:1.00)

(Zito et al.,

2008b). In review, population based analyses of
psychotropic usage patterns have shown variations in use
according to race/ethnicity, type of insurance,

region,

and clinically relevant differences in age group, gender,
and type of condition (Zito, Safer,

& Craig,

2008).

Placement Type
According to the Administration for Children Youth

and Families

(2009), 48% of foster care youth were in

non-relative foster family homes, 24% in relative foster

family homes, 10% were in institutions, and 6% were in

group homes between the dates of October 1, 2008 through

September 20, 2009. Understanding where foster care youth
are placed assist in examining the trends of youth
authorized for psychotropic medications for the current

research.
Overall,

children and adolescents in "substitute

care (by definition eligible for Medicaid benefits)" have
higher rates of mental health services than any other
Medicaid eligible youth (Halfon, Berkowitz, & Klee,

Harman,

Childs,

1992;

& Kelleher, 2000; dos Reis et al., 2001).
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According to Breland-Noble et al.'s 2004 study, level of

care predicts the psychotropic medication use among

foster care youth. Approximately 67% of youths in
therapeutic foster care and 77% of youths living in group

homes are prescribed psychotropic medications.

Influence of Insurance on Authorization
of Psychotropic Medications
Since the 1990s, a dramatic increase in psychotropic

medication use in youth has occurred across all insurance
types

(Zito et al.,

2003). According to Shatin, Levin,

Ireys, and Haller (1998), Medicaid youth, received more

mental health services including psychotropic medications
than employment insurance managed care because of

impairments.
Alarmingly,

the rate of psychotropic medication

prescriptions has increased two to three times in the
past decade (Rubin et al., 2009; Zito et al., 2003).
Especially alarming is the disproportionately with youth

in foster care. Foster care youth represent less than 3%

of all Medicaid enrollees but account for 25% to 41% of
all mental health expenditures for youth within the

Medicaid insurance program (Halfon, Berkowitz, & Klee,
1992; Harmon, Childs, & Kelleher, 2000; Rubin et al.,
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2009). Additionally,

the concern over concomitant

psychotropic medication treatments has increased
dramatically without the evidence to support its safety

and effectiveness with youth (Zito et al.,

1998, 2003,

2008a, 2008b).
Furthermore, according to Ashby,

the General

Accounting Office in Washington, DC, reported that
approximately 1 in 3 states identified the oversight of

psychotropic medication use as the most pressing issues
facing child welfare agencies in the next five years

(as

cited in Rubin, 2009, p. 305). Research indicates that

youth in foster care, covered by Medicaid insurance,
receive psychotropic medication treatment at a rate three
times greater than that of medicated insured youth who

qualified by low family income (Zito et al., 2008a).
Naylor et al.

(2007)

illustrated that foster care

youth diagnosed with ADHD or adjustment disorder were
prescribed stimulant psychotropic medications and

non-stimulant medications. These medications were

prescribed when there has been no empirical research that
has concluded their safety and efficacy with youth
(Naylor et al., 2007) . Nonetheless, according to Zito et

al's

(2008b)

findings from a state Medicaid program in
16

2004, 4 in 10 foster care youth received three different
classes of psychotropic medications. Also,

1 in 5 foster

youth are prescribed concomitant medications where one
out of the two medications were from the same class

(Zito

et al., 2008b).

According to Zito, Safer, and Craig (2008), when
analyzed according to eligibility, foster care youth with

Medicaid insurance receive the highest rates of
psychotropic medications verses youth that are disabled

and have income eligibility. These findings warrant
further research into the trends associated with
authorized psychotropic medications for foster care
youth.

A literature review which examined prescription data
for 300,000 youth from 2000 to 2003, reported that
spending on medications for behavioral problems

overshadow costs for all other drug categories in youth,

including antibiotics (Medco Health Solutions,

Inc.,

2004). The same literature review also concluded that a

369% increase in expenditure on attention deficit

medications for youth under five (Medco Health Solutions,
Inc.,

2004) . Comprehending the trends associated with

authorized psychotropic medications for foster care youth
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may provide insight into the reasons for the significant
increase in psychotropic medications with youth.

Practitioner Impact on Authorizing Psychotropic
Medications for Youth
The U.S. Food and Drug Administration (FDA) does not

limit the approach in which a practitioner may prescribe

an approved drug (Federal Register,

21 CFR Part 201,

1994). This allows physicians to prescribe youth an "off

-label" medication that is not designed for individuals
under age 18

(Crimson & Argo, 2007). The Texas Department

of Family and Protective Services,

in conjunction with

the Texas Department of State Health Services, developed

practice parameters for the use of psychotropic
medication in foster children (Crimson et al., 2007). The

fact that parameters were developed is a step in the
right direction because it allows for oversight in

assessing and over-prescribing medication.
In the past, pharmaceutical companies have been

cautious to fund research on psychotropic medication use
with children. This is one of the reasons why there is
very limited research on psychotropic medications used on

foster care youth (Crimson & Argo,

2007) . Because of the

limited research conducted by pharmaceutical companies,
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practitioners often prescribe medications that do not

have conclusive research of its efficacy with youth

populations.
Additionally, Crismon and Argo (2007)

evaluated the

use of psychotropic medication for children in foster

care. The evaluation focused on thorough assessment
practices by pulling together numerous literature
regarding best practices. They concluded that because

children enter foster care under a great deal of stress,
resulting in behavior disorders, preexisting mental

disorders, or a combination of both, thorough assessment
of the child, their family, and life situations were

essential in determining their best needs

(Crimson &

Argo, 2007).

Theories Guiding Conceptualization

Conceptual theoretical frameworks have been examined
within various research literatures over the
authorization of psychotropic medications for foster care

youth. Social control perspective and eco-systems theory

will be examined for the current research.
Social control perspective refers to the process of
community members conforming to community norms, values,
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expectations, and behaviors

(Lessor & Pope, 2007) . Foster

care youth who suffer from behavioral, emotional, or

mental health problems may be expected to integrate with
the culture of their placement. Moreover,

the American

Academy of Child and Adolescent Psychiatry (AACAP)

is

concerned that psychotropic medications are being used
excessively or improperly as a form of social control to

treat youth in the Juvenile Justice Department and Child

Welfare Services

(AACAP,

2004).

McKay (2007) theorizes that foster care youth are

being prescribed more psychotropic medications because

foster parents, group home staff, and psychiatric

hospitals do not want to deal with the emotional and
behavioral problems that accompany neglected or abused
children. As a result, they request for psychiatric
evaluations in order to receive medications to subdue or
control the youth (McKay,

2007). For example, when a

foster care youth enters a group home for behavioral
problems they are expected to conform to the culture. In

order to accomplish this, they may be given medications

to maintain their behavior as opposed to other forms of
intervention. Foster care youth may also feel pressure to
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adapt to the culture by taking medication after watching
other youth in the placement.

Furthermore, because of the inception of

antipsychotic medication, Cordoba, Wilson, and Orten
(1983), believed many mentally ill clients were able to

live productive lives outside the institutions and

hospitals. Unfortunately, with the increased
understanding of antipsychotic medications and with the

development of the milieu,

therapeutic program

professionals have not decreased the prescription of

antipsychotic medication. Consequently, psychotropic

medication is used as a substitute for lack of
appropriate therapeutic programs.
According to Cordoba, Wilson, and Orten (1983),

youth should not be prescribed antipsychotic medications
for long periods of time without proper assessment.

Assessment should include; if the drug is being used

because of insufficient treatment or programs, has the

caregiver and client been fully advised of side effects
of these drugs, and whether the youths' behavior is

reasonable under the circumstances in which he or she
lives. Additionally,

Cordoba, Wilson, and Orten (1983)

stress the importance of assessing whether a client's

21

feelings are being masked inappropriately due to a lack

of available treatment options.
Lastly,

it is known that foster care youth that are

diagnosed with a mental, emotional, or behavioral problem

receive more funding for additional resources, which is
financially advantageous for foster parents, group homes,

and psychiatric facilities

(McKay, 2007) . McKay theorizes

that many psychiatrists or primary care physicians are
encouraged by foster parents, social workers, and
residential staff to prescribe psychotropic medications

to foster care youth make them more compliant and easier
to handle (McKay,

2007) . Looking at the youth and their

environment is also pertinent.
Eco-systems theory plays a role in how and why
medications are prescribed to foster youth. Eco systems
theory is a way of conceptualizing the relationship

between people and their environment and encourages a

balanced approach to both entities. The theory focuses on
how one's family, community, social, economic, and
political factors affect their situation (Lesser & Pope,

2007). Foster care youth relocate multiple times in the

course of their childhood and receive medical services

from several different providers. At some point between
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moving from various locations, previous diagnosis and

prescribed medications are lost in the system. For

example, Medicaid tends to have a poor tracking system
for program participants and their medical history.

Because of this factor, it is theorized that oversight
and possible inappropriate prescribing of medications may
be a contribution to the increase of psychotropic

medication for foster care youth (Zito et al.,

1998).

In addition, the current practitioner may not be
aware that the youth is receiving prescriptions from

multiple providers. This is due to either not
appropriately assessing the youth for current or prior

medications or the foster youth not telling current usage
(Managed Care, 2010). Improving the cross communication
among various caregivers can improve and decrease the

possibility of this happening.
Also, foster youth tend to present behavior

problems. Therefore, psychosocial treatment may be more

effective over time. However, that is not necessarily the
easiest or the quickest solution, mainly because
practitioners have a significant amount of pressure to
ensure a "quick fix"

(Managed Care, 2010). Again,

improving the use of data to identify quality-prescribing
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practices for foster youth may diminish concerns over

medication (Managed Care, 2010).

Summary

As shown,

the previous research literature related

to the present study shows that there is a clear increase
in psychotropic medication usage among foster care youth.

Further research linking the trends to age, gender,

ethnicity, and placement type may provide education,

insight for further assessment and reappraisal of current

insurance policies. This will ensure that this vulnerable
population is receiving the best mental health treatment

available to them. Additionally, previous research

examined various aspects of the issue. However,

they

lacked to recognize how trends for age, gender,

ethnicity, and placement type may influence foster care
youth prescribed psychotropic medications in California.

The present study aims to bring insight regarding the
trends in prevalence of foster care youth prescribed

psychotropic medications in Los Angeles County compared
to California over the last ten years.
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CHAPTER THREE

METHODS

Introduction

This chapter includes a thorough description of the
research methods and procedures that were utilized for
this research study. Attention was given to the design of

the study, data collection and instruments, procedures,

and methods of data analysis.

Study Design

The purpose of the present study was to describe the

characteristics of foster care youth authorized for
psychotropic medication in California. Specifically,

the

present study described and compared the trends of
gender, age, placement type, and ethnicity over a
ten-year period from 2001-2010 in Los Angeles County and

the state of California as a whole.. The individual

variables of gender, age, placement type, and ethnicity

were extracted from the Child Welfare Research Center
(CWRC). The CWRC is an interagency agreement with

California Department of Social Services (CDSS) and
quarterly extracts from the Child Welfare Services Case

Management System (CWS/CMS). CDSS and Stuart Foundation
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fund the Performance Indicators Project, which provides
timely and useful data about youth who are in
California's Child Welfare System (Needle et al., 2010).
The present study utilized the data that included
authorization of psychotropic medication with foster care

youth. Secondary data analysis was utilized with the

intent to describe the characteristics of foster care
youth who were authorized to receive psychotropic

medication within the state of California compared to Los

Angeles County.
Additionally, the study provided a numerical picture

of the number of foster care youth that validated trends

within these characteristics. This research method was
ideal in order to describe the broader population, which
exists. Given the ability to avoid the collection of

original data, employing quantitative descriptive
secondary data analysis is both time and cost efficient.

Furthermore,

implementing secondary data analysis allowed

for the gathering of more precise descriptions of

geography, gender, age, placement type, and ethnicity

over a ten-year period.
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This type of study design allowed researchers to
answer valuable questions, which compared Los Angeles

County and the state of California,
1.

such as:

How do foster care youth that are authorized
for psychotropic medication in placement differ
over time?

2.

How do foster care youth that are authorized
for psychotropic medication in the various age
groups compare to each other over time?

3.

How do foster care youth that are authorized
for psychotropic medication in various ethnic
groups compare to each other over time?

4.

How do males in the foster care system
authorized for psychotropic medication compare

to females in the foster care system authorized
for psychotropic medication over time?

Although there are strengths with utilizing
quantitative descriptive secondary data analysis,
methodological limitations also exist. There may be a

threat to reliability and validity of the data due to the
tendency of counties to report socially desired
information. Also, inconsistency of how social workers

interpret information inputted in CWRC may apply,
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increasing the prevalence of missing data within the

database, which impacted results. Another major
limitation to this study was the inability to use
inferential statistics due to the aggregate format of the

data, limiting the statistical utility of the data.

Sampling
The secondary data samples were obtained from CWRC,

which included all of California's foster care youth as

reported by the individual counties. CWRC receives data
from all California counties regarding various aspects of
child maltreatment allegations, service delivery,

caseload count, rates, safety, reunification, adoption,
long term care, placement stability, siblings, distances,
and maps of foster care youth within California (Needles
et al., 2010).

The present study examined only the data extracted
for service delivery pertaining to the authorization of
psychotropic medications for foster care youth, which

included information on ethnicity, age, gender, placement
type, and geographical location. All of the data
extracted came from CWRC between the periods of

2001-2010. The data extracted are reportedly pulled
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-

approximately two months after each quarter ends. Due to

the time it takes to process the data each quarter, data

will be typically 6 to 9 months old (Needles et al.,
2010).

Data Collection and Instruments
The present study employed quantitative descriptive

secondary data analysis gathered from CWRC. Several

variables were analyzed to determine their specific
trends in relation with authorized psychotropic
medication usage in foster care youth. Each variable was

extracted individually in order to receive a more in
depth look at the trends.
Geographical location was assessed first by

examining the total foster care youth authorized to
receive psychotropic medication in California. Secondly

Los Angeles County foster care youth was extracted from
the total data, which allowed comparison between Los
Angeles County and state of California's trends. Gender

was examined by separating male and female foster care

youth. Age was divided into seven categories; under one
year, 1-2 years, 3-5 years, 6-10 years,

11-15 years,

16-17 years, and 18-20 years. In order to describe the
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trends of placement type in foster care youth authorized

to receive psychotropic medication, data was extracted
through fifteen classified categories. These categories
include Pre-Adopt, Kin, Foster, Foster Family Agency
(FFA), Court Specified, Group,

Shelter, Non-Foster-Care,

Transitional Housing, Guardian - Dependent, Guardian -

Other, Runaway, Trial Home Visit, and Other.
The relationship between ethnicity and authorized

psychotropic medication use in foster care youth was

analyzed through five ethnic groups; Black, White,
Hispanic, Asian/Pacific Islander, and Native American.
Lastly, geographical location, gender, age, placement
type, and ethnicity were described over a ten-year

period. The time periods were grouped by yearly intervals

beginning January 2001-January 2010.

Procedures

In order to initiate the present study, approval

from the California State University, San Bernardino
Institutional Research Board (IRB) was needed. A research
proposal was provided that described the nature of the

study. After approval, researchers collaboratively began
extracting data from CWRC in January 2011 through March
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2011. After collecting and interpreting the data trends,
researchers began writing the results of the research in

March 2011. April 2011, researchers wrote Chapter Five,
the Discussion pertaining to the data trends discovered

after collecting data.

Protection of Human Subjects

Data was collected from the CWRC website, which

provided complete anonymous and confidential data
pertaining to foster care youth authorized for

psychotropic medication to researchers. Because data in

the CWRC website is presented in aggregate form, no

identifiable information pertaining to the participants

in CWRC data sample was provided to the researchers.
Researchers abided by all confidentiality requirements
while writing the present study to ensure that the
anonymity of the participants was respected.

Data Analysis

The data gathered in this study makes use of a
quantitative descriptive secondary data analysis method

in order to understand the characteristic trends of

foster care youth who are authorized for psychotropic
medication use during 2001-2010. Descriptive statistics
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were employed to illustrate the characteristics of the

sample using measures of central tendency (e.g., mean,
median, and mode) and measures of variability (e.g.,

standard deviation). Furthermore,

the researchers

developed tables to describe the trends over the period

of ten years. Each table illustrated the data for
authorized psychotropic medication use among foster care

youth as it relates to a specific variable such as
geographical location, gender, age, placement type, and

ethnicity over time. Because the available data is in

aggregate form, there is no individual level data.

Therefore,

inferential statistical procedures were not

used to answer the research questions, and apparent
differences in groups and trends in the data are

discussed but not tested.

Summary

The research method employed in this study is a

quantitative descriptive secondary data analysis using

CWRC data set. CWRC was used to collect information on
the dependent variables (geographical location, gender,
age, placement type, and ethnicity)

over a ten-year

period. The data analyzed by extracting each dependent
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variable and graphing trends as they relate to
authorization of psychotropic medication use in foster

care youth was utilized.
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CHAPTER FOUR

RESULTS

Introduction

This chapter provides an overview of the variables
examined of the foster care youth that have been

authorized for psychotropic medication in California and

Los Angeles County, respectively. The quantitative

descriptive secondary data analysis of all the counties
in California is demonstrated through describing the

relationship between these variables examined. The

variables are further expressed through the demonstration
of tables and charts.

Presentation of the Findings

The random sample of foster care youth for this

study was obtained from CWRC, which included county level
data from all of California's counties. Table 1

illustrates the total number of foster care youth in the

state of California compared to Los Angeles County at the
beginning of this study and at the completion. Utilizing

CWRC, as of April 2001 there were 102,214 total foster
care youth in California with 40,280 youth in Los Angeles

County specifically. At the completion of the study in
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April 2010, there was a significant reduction in foster

care youth in California to 61,907 with only 20,452 in
Los Angeles County. This data is important to consider
for the current research due to the impact the total'
number of foster care youth being greatly reduced over

time.

Table 1. Total Number of Foster Care Youth

April 2001

April 2010

California

102,214

61,907

Los Angeles

40,280

20,452

(39.4% of total)

(33.0% of total)

Percentage

Table 2 demonstrates the total amount of foster care
youth that were authorized psychotropic medication during
the studies time period. According to CWRC,

in April

2001, California had 1,968 foster care youth authorized

for psychotropic medication with Los Angeles County
having 860 of these youth authorized psychotropic

medication. At the conclusion of the study in April 2010
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the total number of foster care youth authorized for
psychotropic medication in California was 8,556 with

2,981 specifically in Los Angeles County.

Table 2. Foster Care Youth Authorized Psychotropic

Medication

April 2001

California

1,968

Los Angeles

860

(1.9%)

(2.1%)

April 2010

8,556

(13.8%)

2,981

(14.5%)

Results of the Research Questions Asked
1. How do foster care youth that are authorized for
psychotropic medication in placement differ over time?

Overall, Los Angeles County foster care youth in
placement were authorized psychotropic medication at

higher rates than the state of California as a whole.
Before October 2003, youth in placement in Los Angeles
County and California were parallel. After October 2003,
there was a significant increase of 4% in authorization

for psychotropic medication for Los Angeles County foster

care youth. The increase maintained steady until 2008. At
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this time,

California's rate of authorization increased

to parallel that of Los Angeles County's authorization

rate. Between 2008 and 2010, there was approximately 1%

difference in authorization for placement.

Figure 1. Youth Authorized for Psychotropic Medication in

California and Los Angeles: Placement Type
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2. How do foster care youth that are authorized for
psychotropic medication in the various age groups compare
to each other over time?

In Los Angeles County, the sample illustrated an

increase in authorization for psychotropic medication for
foster care youth between the ages of 6-18 years of age.

Youth between the ages of 6-10 demonstrated an increase

to approximately 12% in 2005 to 2006. In 2006 to 2008,
authorization for foster care youth between 6-10 years of

age declined from 12.1% to 10.9%. Between the years of
2008 to 2010, authorization appears to have increased

from 12.1% to 12.6%. In 2001, approximately 5% of youth

between the ages of 11 and 18 years of age were
authorized medication. Youth between the ages of 11-15

and 16-17 years of age paralleled in their increase of
authorized medication (22%) until approximately 2008. In

2008, authorization for youth between the ages of 16-17

increased approximately from 23.5% to 29.5% in 2010.
Youth 18 years of age appeared to have a slow increase in
authorization of medication from 2002 to 2010. Peak
authorization for 18 year olds was approximately 31% in

2010. Authorization for psychotropic medication did not
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have a significant increase for foster care youth 5 and
under (under 1,

1-2,

3-5 years).

Figure 2. Foster Care Youth Authorized for Psychotropic
Medication in Los Angeles: Ages 0-18

In California,

the sample showed a similar increase

in authorization of psychotropic medication between age

groups to Los Angeles County. Youth between the ages of
6-18 years of age illustrated an increase in

authorization starting in 2001. Foster care youth between
6-10 years of age were authorized for medication at a

stable rate until 2008

(10%) when it demonstrated a

steady increase till 2010

(14%). Youth between 11-15 and

16-17 increased at an approximately parallel rate till
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2010. Peak authorization for 16-17 years olds occurred in
2010 with approximately 26%. California foster care youth

18 years of age, appeared to have a slow increase in
authorization until 2003, when they started to steadily

increase till 2010 with approximately 24%. Authorization
for psychotropic medication did not have a significant
increase for foster care youth 5 and under (under 1, 1-2,

3-5 years). Youth ages 2 and under did not have any
authorization for medication between 2001 and 2010. Youth

between 3-5 years of age authorized for medication peaked
at 1.4% in 2009.
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Figure 3. Foster Care Youth Authorized for Psychotropic
Medication in California: Ages 0-18

40

3. How do foster care youth that are authorized for
psychotropic medication in various ethnic groups compare

to each other over time?

In Los Angeles County, up until 2003 all the ethnic

groups remained relatively stable with rates under
approximately 5%. Overall, black foster care youth were

authorized more psychotropic medications than their peer

groups. On the other hand, the Asian/Pacific Islander

ethnic group had the least rate of authorization for
psychotropic medication out of their peer groups.

Immediately following 2003, all ethnic groups had an

increase in authorization for psychotropic medication.
Black and white ethnic groups paralleled each other until

2005. Black and white ethnic groups had a significant
increase in authorization rates of’approximately 9%,

from

5.2% to 14.4%, between 2003 and 2005. Hispanic and
Asian/Pacific Islander ethnic groups paralleled each

other at a stable authorization rate from 2004 to 2010.

Native American ethnic group had scattered authorization
rates between 2006 and 2010. They peaked in 2008 to
approximately 18.4%,

1% higher than their Black

counterparts.
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Figure 4. Foster Care Youth Authorized for Psychotropic
Medication in Los Angeles: Ethnicities

For the state of California, Black and White ethnic
groups paralleled each other for the ten-year span.

However, between 2005 and 2008 the Black ethnic group

showed a 1% increase,

compared to the White ethnic group,

in authorization. Unlike Los Angeles County, Native

Americans in California as a whole sustained a stable

rate of authorization for psychotropic medication. The
Asian/Pacific Islander ethnic group maintained the lowest

rate of authorization for psychotropic medication,
approximately 1% lower than the Hispanic ethnic group

(9.3% vs 10.9% in 2010, respectively).
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Figure 5. Foster Care Youth Authorized for Psychotropic
Medication in California: Ethnicities

4. How do males in the foster care system that are
authorized for psychotropic medication compare to females
authorized for psychotropic medication over time?

In Los Angeles County, between 2001 and 2003 there

was a minor difference in the authorization of
psychotropic medication for males and females of 1-2%. In

2003, males authorized for medication took a progressive

increase, with a difference of approximately 12% in 2010
(4.9% in 2003, 17% in 2010).
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Female
Male

Figure 6. Foster Care Youth Authorized for Psychotropic
Medication in Los Angeles: Female and Male

In California, between 2001 and 2003 males and

females had a slight increase with males being 1-2%

higher in authorization of medication. From 2003 to 2010

males maintained an approximate 11% increase over females
for authorization of psychotropic medication (5.1% in
2003, 16.5% in 2010).
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Figure 7. Foster Care Youth Authorized for Psychotropic
Medication in California: Female and Male

Summary

The results of this study were discovered by
describing the CWRC data, which represented foster care

youth authorized for psychotropic medication in Los
Angeles County and the state of California. The variables
described included age, gender, ethnicity, and placement

type. Additionally, these variables were compared to each
other over a ten-year time span. Significant findings
demonstrated that foster care youth in Los Angeles County

between the ages of 6-18 years were authorized
psychotropic medication at a higher rate than that of

California.

In addition, males in foster care are
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authorized psychotropic medication at a higher rate than

females,

specifically, in Los Angeles County compared to.

California. Furthermore, the Black ethnic group

maintained higher rates of authorization, while
Asian/Pacific Islander ethnic group maintained lowest

rate of authorization. Lastly,

foster care youth in Los

Angeles County placements are authorized at higher rates
than California as whole.
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CHAPTER FIVE

DISCUSSION

Introduction

This study examined the variables of foster care
youth authorized for psychotropic medication within Los
Angeles County and the state of California as a whole.

The limitations of this study and the recommendations for

social work practice, policy, and research are further

discussed. This chapter will conclude with a
summarization of the purpose of this study.

Discussion
The results of this study found that foster care
youth residing in Los Angeles County have been authorized

for psychotropic medications at a higher rate than the

state of California over the last ten years. At the
beginning of the study, April 2001,

there were 102,214

foster care youth in California, however, at the
completion of the study, April 2010 there were only

61,907 foster care youth in California. This information
is noteworthy because of the significant reduction in

youth in foster care, although, on the other hand
authorization rates increased significantly. In April
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2001, California had 1,968 foster care youth authorized

for psychotropic medications but concluded in April 2010

with 8,556 foster youth authorized for psychotropic
medication, a change from 1.9% to 13.8%. This is a

momentous increase that is pertinent to the social work
practice and relevant to the today's foster care system.

The current study found that youth in placement in
Los Angeles County were authorized psychotropic
medication at higher rates than that of California as a

whole. Due to the limitations of CWS/CMS database,
researchers were unable to extract specific placement

types. However, data shows that after 2003 there was a
significant increase from 8% to 14.6% in authorization

rates for Los Angeles County foster.care youth, which is
a very rapid increase and worth noting.

Past studies are severely limited on specifics
pertaining to the relationship between placement types

and psychotropic medication authorization. The current
researchers recommend that further investigative research

be conducted in this area.
The current study found that youth between the ages

of 6-10 years of age had the most remarkable increase of
authorization of psychotropic medication. Additionally,
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the current study did not find a significant increase in

utilization of psychotropic medication for youth under
the age of five.

The findings of Robst, Armstrong, and Dollard's 2009
study support the results of the current study. Robst,

Armstrong, and Dollard found that antipsychotic

medication use among youth was higher among youth ages

6-12 compared to youth ages 13-18. Moreover,

the

prevalence of authorization of psychotropic medication
for youth between 0-5 years of age was 12.4% (Zito et

al., 2008a).

Overall, black foster care youth were authorized
more psychotropic medications than their peer groups. For

the state of California, black, and white ethnic groups

had similar rates for authorization of psychotropic
medication, although, black foster care youth maintained

a 1% increase over the ten year time period. Past

studies, however, present contradicting results.
Zito, Safer, dosReis, and Riddle's 2008 study

indicate that Caucasian youth receive more psychotropic
medications than their African-American counterparts.

African-American youth between the ages of 5-14 were less
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likely to be prescribed psychotropic medication than

Caucasian youth (3 9%-52%).
Overall,

in Los Angeles County and the state of

California, male foster care youth were authorized for

psychotropic medications at a higher rate than female

foster care youth. In Los Angeles County and California,
males maintained a 1% increase in authorization of
psychotropic medication over females. From 2003 to 2010

this rate increased to approximately 4% over females for
authorization of psychotropic medication.

Past research signify similar results. Zito et al.
(2008b) showed a predominance of boys being prescribed
psychotropic medications than girls.
Considering the current findings of the increasing

rate of authorized psychotropic medication for foster
care youth, one may consider the following possibilities.
The Adoptions and Safe Family Act

(ASFA) was enacted into

Congress in 1997 to reduce the length of time a youth
spends in foster care. However,

California counties began

implementing ASFA in 2001, but became fully implemented
in 2003

(L. Brown, personal communication, April 14,

2011). Consequently, because of ASFA, California child
welfare departments found different avenues other than
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foster care. For example, cases were more likely to be
referred to family preservation or adoptions.
Proportionately speaking, youth in foster care after 2003

were more likely to have experienced trauma and abuse

than those pre 2003. Therefore, youth currently in foster
care are experiencing more trauma, neglect,

and or abuse

resulting in the necessity for authorization of
psychotropic medication (L. Brown, personal
communication, April 14, 2011). This information
corresponds with past research,

such as, Breland-Noble et

al.7s 2004 study, in which they found that over half of
youth were in therapeutic care or in a group home. This
shows that level of care predicts the psychotropic

medication use among foster care youth.
Secondly, the general trend in the increased
prescribing of psychotropic medications may be due to the

lack of empirical research on the efficacy of
psychotropic medication on the youth population.

Pharmaceutical companies have been wary to fund research

on psychotropic medication with youth (Crimson & Argo,
2007),

resulting in medications prescribed without

knowledge of their safety and efficacy on youth (Naylor
et al., 2007) .
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Additionally, the U.S. Food and Drug Administration

does not limit the approach in which a practitioner may
prescribe an approved drug (Federal Register,
201,

21 CFR Part

1994). Therefore, youths are prescribed "off-label"

medications not designed for youth under 18 years of age,
as well as concomitant medications

(Crimson & Argo,

2007). According to past research, 4 in 10 foster care
youth received three difference classes of psychotropic
medication and 1 in 5 foster care youth are prescribed
concomitant medications (Zito et al.,

2008b).

Furthermore, reporting to CWS/CMS database has
reportedly improved significantly post 2003

(L. Brown,

personal communication, April 14, 2011). For that reason,
data collected after 2003 is believed to be more accurate
than previous data. Additionally,

improvement in

reporting can be noted to the child welfare departments'

interest in collecting data pertaining to foster care
youth.

Finally,

the decrease of authorization for

psychotropic medication in Los Angeles County (39% of the

total population in California to 33%) may be attributed
to the closing of Los Angeles County's Assessment center
(L. Brown, personal communication, April 14,
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2011).

Limitations

The main limitation of this study was the inability

to extract individual data from the CWS/CMS data. The
researchers were unable to extract individual data
pertaining to specific placement types, ethnicity
background ratio, and missing data, which may have

enhanced the research findings. This prevented

inferential statistical methods from being used on this

data. However, utilizing secondary data was beneficial

because it provided researchers access to an abundance of
California foster care youth.

Some of the data was unable to be used for the
current study due to CWS/CMS excluding data for foster

care youth over the age of 18 years. Researchers excluded
missing data for ethnicity because the numbers were

considered negligible. Additionally, CWS/CMS did not
include missing information for those who did not fit

under male or female categories, which excluded those who

identified themselves as cross-gendered.
Secondary data collection has limitations due to not

being able to determine what type of data was collected
or how the data was collected in general. Additionally,
every county within California has an interpretation of
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the information that should be entered into CWS/CMS.
Specifically, human error in entering information
pertaining to foster care youth authorized for

psychotropic medication may take place.

Moreover, the results of the current research cannot
be generalized for the entire foster care youth

population within the United States. Data only represents
foster care youth within the state of California.

Also, the specific psychotropic medications and
diagnoses cannot be individually examined which is a

limitation of secondary data analysis. Understanding what

psychotropic medications are being prescribed and for

what diagnosis would allow researchers to examine the

efficacy of the medication on the specific population.
This would also aid in understanding how youth respond to
these medications and whether they are actually improving

negative symptoms in,foster care youth.

Recommendations for Social Work
Practice, Policy and Research
Foster care youth are a very vulnerable population

that is being prescribed psychotropic medication at a
significant rate. This issue affects the social work

practice, policy, and research,
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in addition to society as

a whole. It is important for professionals working with
the foster care population to be aware of the elements

that accompany utilization of psychotropic medication.
Therefore, it is recommended that foster care social
workers collaborate with foster care parents,

psychiatrists, therapists, and foster care youth when
authorizing psychotropic medication treatment to ensure

appropriate medication is being prescribed.
Implementing psychopharmacology education for social

workers that work directly with foster care youth would
ensure that they would be educated, aware, and informed

on the issues of how age, ethnicity, gender, and
placement types affect authorization of psychotropic

medications. Social workers are often case managers to
foster care youth and need to be strong advocates in case

consultations and team decision meetings by providing
information on psycho-education about medications and

potential side effects to caregivers and youth (Bentley,
Walsh, & Farmer,

2005).

Furthermore, educating the youth and their
caregivers is equally important. This will allow the

youth and caregiver to feel empowered and to lend them
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the ability to advocate for the most appropriate
treatment.
Currently,

the law requires juvenile courts to

approve psychotropic medication based on information

provided by the child's social worker and doctor
(Childlaw,

2 009) . Often, social workers are uneducated on

the specifics of the effects and side effects of
psychotropic medications. Also, the doctor may not have

the foster care youth's entire history due to placement

disruptions. This is concerning considering the
prevalence of authorization of psychotropic medication in

the state of California for foster care youth. In order
for this law to be effective is if social workers were

educated on psychopharmacology and doctors had correct

histories on all foster care youth in order to make the
best diagnosis and prescribe accordingly.

Finally,

it is recommended that more research be

conducted on foster care youth's based on the prevalence

of authorization of psychotropic medication.
Specifically,

the number of prescriptions, diagnosis

associated with the psychotropic medication, short and

long term effects of psychotropic medications, and actual

efficacy on the youth population. It is advisable for the
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social work profession to research further
non-pharmaceutical treatments for foster care youth

suffering from mental illness, emotional, and behavioral
problems.

Conclusions
The purpose of this study was to describe the trends
of foster care youth who are authorized psychotropic

medication in Los Angeles County and California over a
ten-year span. This study collected data from CWS/CMS

database, which had approximately 8,556 foster care youth
in the state of California who were authorized
psychotropic medication. This study found that foster

care youth in Los Angeles County were authorized
psychotropic medication at a higher rate than youth in

the state of California overall for gender, age,
ethnicity,

and placement.

The limitations of this study were identified and
addressed. The main limitation was due to the CWS/CMS
data sample, which only examined trends and not

individual domains. As the limitations were addressed,
recommendations for social work practice, policy, and
research were proposed. Some recommendations were to

57

further educate social workers that work directly with

foster care youth, improve foster care youth histories

for doctors, and further collaboration between

caregivers, physicians, social workers, and youth. Foster

care youth are society's vulnerable population and are at
a high-risk for being prescribed psychotropic medication
therefore continued research and advocacy is warranted.
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APPENDIX
DATA EXTRACTION PROTOCOL
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CWRC Data Extraction Protocol

Foster Care Youth Authorized Psychotropic Medications

AGE (Ration/lnterval
Under 1 year of age
I-2 years
3-5 years
6-10 years
II- 15 years
16-17 years
18-20 years
GENDER (Nominal)
Female
Male
ETHNICITY (Nominal)
Black
White
Hispanic
Asian/Pacific Islander
Native American
PLACEMENT TYPE (Nominal)
Pre-Adopt
Kin
Foster
Foster Family Agency (FFA)
Court Specified
Group
Shelter
Non-Foster Care
Transitional Housing
10. Guardian/Dependent
11. Guardian/Other
12. Runaway
13. Trial Home Visit
14. Other
15. Missing

GEOGRAPHICAL LOCATION (Nominal)
California State
Los Angeles County
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